Oncology & Cancer

The goldilocks of radioisotopes, just right for treating cancer

Cutting across demographic and geographic lines, cancer remains the second-leading cause of death in the United States. According to the National Cancer Institute, more than one in three men and women in America will be diagnosed ...

Radiology & Imaging

New imaging-based approach to measure radiation dose

Some types of cancer and other diseases are treated with a drug containing radioactive material that targets the tumor. However, the drug can also be deposited in healthy organs, potentially damaging the kidneys, gut or bone ...

Oncology & Cancer

First Phase III trial of an alpha-pharmaceutical

Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong ...

Oncology & Cancer

Promising ovarian cancer treatment proves effective and efficient

Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant ...

Oncology & Cancer

High-impact radiopeptide therapy halts neuroendocrine cancer

Research introduced at SNM's 58th Annual Meeting could be a sign of hope for patients with neuroendocrine cancer not responding well to standard therapies. Most radiotherapies use medical isotopes that emit beta radiation. ...

Medical research

Liver structure could hold the key to battling diabetes

(Medical Xpress) -- Our liver could be a major springboard for determining life-changing diabetes diagnosis and treatment thanks to a world-first discovery by an Australian-Chinese research team.

Medical research

Can targeted therapies be applied to patients with Alzheimer's?

Alzheimer's disease, a debilitating brain disorder with limited treatment options, has long challenged researchers. Specifically, researchers have struggled with slowing the buildup of amyloid beta plaques, harmful clumps ...

Medical research

Tunable bonds: A step towards targeted At-211 cancer therapy

Astatine is the least abundant element on Earth, and all of its known isotopes have a half-life of less than 8 hours. One astatine isotope, astatine-211 (At-211), emits alpha particles and shows promise as a cancer therapy. ...

page 1 from 2